Therapeutic Drug Monitoring Market Report | Size, Analysis 2023

The global therapeutic drug monitoring market size was valued at USD 2.2 billion in 2022 and is poised to grow at a significant CAGR of 4.3% during the forecast period 2023-29. Glance our 200 slides market research and competitive intelligence research report, 25 Tables and 65 Figures and other qualitative sections with an in-depth TOC on “Therapeutic Drug Monitoring (TDM) Market: By Drug Type (Antibiotics, Addiction Therapeutics, Alzheimer Disease, Analeptics, Analgesics, Antiarrhythmic, Anticancer, Anticoagulants, Antidepressants, Antiepileptics, Anti-HIV, Antihypertensive, Antipsychotics, Hormones, Immuno-Suppressants, Antifungals), By Technology (Immuno- Assay, Mass Spectrometry, GC-MS/MS, Others), By End User (Hospital Laboratories, Private Laboratories) - Global/Region/Country Forecast to 2028.”

View the detailed report description here - https://precisionbusinessinsights.com/market-reports/global-therapeutic-drug-monitoring-market/



Increasing number of organ transplantation cases around the globe estimated to boost the Therapeutic Drug Monitoring Market:
Therapeutic drug monitoring is the method used to measure drug metabolites or drug concentrations in plasma. It is the clinical evaluation of drug’s pharmacokinetic properties. It is generally performed for narrow therapeutic index drugs. This method helps in diagnostic purpose, reduces drug toxicity and enhances drug efficacy. Imipramine, Amitriptyline, Clomipramine and Nortriptyline are the tricyclic antidepressants often preferred for therapeutic drug monitoring because of their slow onset of action the difficulty of evaluating dose-effect and the marked interindividual variability of steady-state plasma concentration. Patients make use of ISD’s generally undergo therapeutic drug monitoring due to their severe adverse effects, variability in blood concentrations between individuals and their narrow therapeutic index.

One of the key factors anticipated to bolster the therapeutic drug monitoring market is the increasing number of organ transplantation cases across the globe. Almost 100,791 people await kidney transplants and over 3000 new patients are added to the kidney waiting list every month according to the World Health Organization (WHO) in November 2016. Furthermore, development of technologically advanced instruments as well as adverse effects associated with the drugs enable the therapeutic drug monitoring market growth over the future period. In addition, there are a few more factors estimated to impel the therapeutic drug monitoring market over forecast period are the development in healthcare infrastructure, growing R&D activities to develop test kits and growing adoption of therapeutic drug monitoring in emerging dcountries.

Request sample report at https://precisionbusinessinsights.com/request-sample/?product_id=20609


North America got larger revenue share in the global therapeutic drug monitoring market with moderate CAGR rate. Factors that are impelling the market growth in this region are surge in prevalence of chronic diseases, Increase in the adoption of therapeutic drug assays by the healthcare professionals and the innovation of advanced test kits by the market players. Asia Pacific market estimated to grow at considerable rate because of the launch of the novel test kits into market, increase in the number of patients suffering from chronic diseases in Japan, India and China and development in healthcare infrastructure.

The global therapeutic drug monitoring market key players are ARK Diagnostics, Inc., Beckman Coulter, Ortho Clinical Diagnostics, Sekisui Diagnostics, Sekisui Medical Co. Ltd., SJK Global, LLC, Chromsystems and Meridian Healthcare S.R.L.